Cytomegaloviral disease, including avohilmo

AB1_CMV_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — B25 Hospital discharge: ICD-10 — B25 Hospital discharge: ICD-9 — 078[5] Hospital discharge: ICD-8 — 079[5] Cause of death: ICD-10 — B25 Cause of death: ICD-9 — 078[5] Cause of death: ICD-8 — 079[5] 3 out of 7 registries used, show all original rules.	1227
4. Check minimum number of events None	1227
5. Include endpoints None	1227
6. Filter based on genotype QC (FinnGen only)	880

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_VIRAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_CMV_WIDE
CONTROL_EXCLUDE	AB1_OTHER_VIRAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	B25
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B25
HD_ICD_9	078[5]
HD_ICD_8	079[5]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B25
COD_ICD_9	078[5]
COD_ICD_8	079[5]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cytomegaloviral disease, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	880	446	434
Unadjusted period prevalence (%)	0.18	0.16	0.20
Median age at first event (years)	54.11	52.25	56.02

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
939: Matched controls
9390

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

108.6

314.6

162

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

111.5

307.9

158

L04AD01

ATC

ciclosporin; systemic

48.2

307.7

239

A11CC03

ATC

alfacalcidol; systemic

36.3

307.7

221

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

126.1

307.7

222

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

54.3

307.7

246

TK800

NOMESCO Finland

Hemodialysis

43.6

307.7

234

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

19.6

307.7

363

293

L04AD02

ATC

tacrolimus; systemic

92.7

307.7

247

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

+∞

307.7

428

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

46.7

307.7

244

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

+∞

307.7

375

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

18.3

307.7

312

248

L04AA06

ATC

mycophenolic acid; systemic

88.5

307.7

375

127

Kela drug reimbursment

Transplant complication

139.3

307.7

419

Z94.0

ICD-10 Finland

Kidney transplant status

111.5

307.7

265

B03XA02

ATC

darbepoetin alfa; parenteral

37.8

298.9

191

H02AB04

ATC

methylprednisolone; systemic

10.9

296.3

454

744

Z49.1

ICD-10 Finland

Extracorporeal dialysis

52.5

283.3

165

A12AA04

ATC

calcium carbonate; oral

46.8

272.3

163

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

64.2

254.9

142

R50.9

ICD-10 Finland

Fever, unspecified

9.0

250.6

452

874

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

9.4

250.5

412

718

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

16.9

246.9

226

173

137

Kela drug reimbursment

Uraemia requiring dialysis

74.6

238.1

129

N18.8

ICD-10 Finland

Other chronic renal failure

33.4

231.0

152

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

14.4

224.6

226

202

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

54.7

222.9

128

XW000

NOMESCO Finland

Bone marrow biopsy

16.1

217.8

202

157

A49.9

ICD-10 Finland

Bacterial infection, unspecified

8.8

203.2

324

533

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

19.5

198.5

163

100

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

103.9

197.2

102

B05DA

ATC

Isotonic solutions

64.8

196.6

109

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

38.8

195.4

122

V03AE01

ATC

polystyrene sulfonate; oral

43.0

192.8

117

N18.0

ICD-10 Finland

End-stage renal disease

50.7

192.2

112

L04AA01

ATC

[U] ciclosporin

41.6

191.2

117

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

99.4

188.5

A05AA02

ATC

ursodeoxycholic acid; oral

29.2

188.4

129

Z49.2

ICD-10 Finland

Other dialysis

58.8

177.2

100

Z49.0

ICD-10 Finland

Preparatory care for dialysis

41.5

175.0

107

B05DB

ATC

Hypertonic solutions

62.8

172.3

C03CA01

ATC

furosemide; systemic

6.1

170.3

490

1418

WW500

NOMESCO Finland

Blood transfusion

12.6

156.2

165

156

V03AE02

ATC

sevelamer; oral

76.8

156.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

25.3

153.1

110

TPX10

NOMESCO Finland

Implantation of vascular injection port

14.1

150.0

146

121

ZX120

NOMESCO Finland

Intravenous

7.5

148.9

257

450

L04AX01

ATC

azathioprine; systemic

11.5

148.4

167

173

L03AA02

ATC

filgrastim; parenteral

14.1

145.4

141

116

196

Kela drug reimbursment

Paricalcitol and cinacalcet

66.3

143.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.8

141.2

361

919

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

67.8

136.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

42.1

133.5

KBV00

NOMESCO Finland

Insertion of stent into ureter

42.1

133.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

45.3

132.6

M04AA01

ATC

allopurinol; systemic

6.3

132.4

279

592

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

8.0

130.7

202

311

WW200

NOMESCO Finland

Immunization

14.4

129.7

123

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.8

124.6

512

1884

ZX108

NOMESCO Finland

Inhalation

34.4

118.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.1

115.9

685

3260

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

58.1

115.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.3

114.9

232

468

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.2

107.7

129

144

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

48.2

107.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

8.3

106.8

153

214

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

58.2

106.3

Z94.4

ICD-10 Finland

Liver transplant status

62.9

106.0

H05BX01

ATC

cinacalcet; oral

37.3

105.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

8.6

105.4

147

199

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.3

104.0

415

1455

B03XA01

ATC

erythropoietin; parenteral

32.7

103.0

TGC00

NOMESCO Finland

Bronchial lavation

10.9

97.3

110

113

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.6

96.5

121

143

TK820

NOMESCO Finland

Peritoneal dialysis

45.7

94.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

10.0

90.1

108

120

JN4AD

NOMESCO Finland

Body CT examination

4.9

89.9

240

611

A41.9

ICD-10 Finland

Sepsis, unspecified

9.5

89.0

111

130

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

33.6

88.5

R4110

NOMESCO Finland

Physiotherapy

3.8

88.1

443

1784

H02AB09

ATC

hydrocortisone; systemic

11.4

87.3

KA1AE

NOMESCO Finland

Kidney ultrasound examination

11.4

85.5

J01MA12

ATC

levofloxacin; systemic

4.2

85.4

309

989

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

35.7

85.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

7.4

85.1

134

207

TPH04

NOMESCO Finland

Cathetrisation of vein

3.9

84.6

365

1320

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

13.1

84.1

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

24.6

83.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.0

79.3

202

491

Z2446

NOMESCO Finland

Social worker

5.6

77.0

166

349

321

Kela drug reimbursment

Paricalcitol and cinacalcet

26.0

77.0

V03AE03

ATC

lanthanum carbonate; oral

43.9

76.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

6.2

75.9

143

265

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

16.3

74.0

GD1AD

NOMESCO Finland

Thorax CT examination

5.7

73.1

150

301

B34.9

ICD-10 Finland

Viral infection, unspecified

13.5

70.7

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

14.1

70.5

A10AC01

ATC

insulin (human); parenteral

5.2

69.5

160

355

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.2

69.5

159

351

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

68.3

384

1608

D70.89

ICD-10 Finland

Neutropenic splenomegaly

17.3

68.1

205

Kela drug reimbursment

Chronic hypertension

3.5

68.1

330

1261

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

18.2

67.5

ZXE20

NOMESCO Finland

More than three and less than five hours

4.0

66.0

231

709

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.5

65.9

301

1104

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

65.3

401

1761

A07AA09

ATC

vancomycin; oral

16.6

64.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.2

64.3

202

573

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

11.6

63.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.6

62.8

277

990

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

21.5

62.2

ZXD05

NOMESCO Finland

Urgent procedure

3.1

62.0

413

1889

J05AB11

ATC

valaciclovir; oral

3.7

61.5

249

841

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

+∞

61.1

TPH07

NOMESCO Finland

Cathetrisation of artery

4.1

61.1

197

568

B99

ICD-10 Finland

Other and unspecified infectious diseases

11.2

61.0

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

13.7

60.1

KBV10

NOMESCO Finland

Removal of stent from ureter

21.4

59.5

C02AC05

ATC

moxonidine; oral

6.6

59.4

102

171

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

59.3

229

748

C08CA01

ATC

amlodipine; oral

3.0

59.1

465

2318

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.1

59.1

110

200

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.2

58.7

343

1447

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.6

58.7

248

859

H3603, E103,

ICD-10 Finland

19.3

58.1

A10AB05

ATC

insulin aspart; parenteral

4.6

57.6

153

380

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

8.4

56.9

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

205.8

56.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

18.1

55.2

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.3

55.1

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.8

55.0

109

C90.0

ICD-10 Finland

Multiple myeloma

17.5

54.2

H26.3

ICD-10 Finland

Drug-induced cataract

19.9

53.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

8.7

53.6

J01MA14

ATC

moxifloxacin; systemic

4.2

53.6

163

448

WX892

NOMESCO Finland

Monitored bed care

4.4

52.6

146

374

R4190

NOMESCO Finland

Nutritional therapy

5.6

52.3

107

212

A07AA02

ATC

nystatin; oral

5.6

52.3

107

212

J01MA02

ATC

ciprofloxacin; systemic

2.8

50.4

461

2433

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.5

49.6

RS220, ,

NOMESCO Finland

11.4

49.0

N17.8

ICD-10 Finland

Other acute renal failure

13.8

48.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.7

48.2

519

2952

K65.0

ICD-10 Finland

Acute peritonitis

15.7

47.9

D64.9

ICD-10 Finland

Anaemia, unspecified

4.0

47.6

155

446

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

47.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.0

47.1

153

439

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

47.1

136

358

JN4BD

NOMESCO Finland

Extensive body CT

3.8

46.8

165

501

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

17.2

45.5

C08CA02

ATC

felodipine; oral

4.1

45.4

138

377

C07AG02

ATC

carvedilol; oral

4.9

45.1

108

245

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.7

45.0

166

519

H43.1

ICD-10 Finland

Vitreous haemorrhage

7.8

45.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.3

44.5

199

H02AB06

ATC

prednisolone; systemic

2.6

44.4

547

3277

WZC00

NOMESCO Finland

Treatment plan or consultation

2.6

44.4

463

2563

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.8

44.1

159

WX872

NOMESCO Finland

Intensive care

5.0

43.5

101

223

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

10.9

43.2

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.8

42.8

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.4

42.8

176

590

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.6

42.7

A41.8

ICD-10 Finland

Other specified sepsis

8.9

41.6

0785A

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[MONONUCLEOSIS INFECTIOSA CYTOMEGALICA]

+∞

40.9

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6.1

40.8

127

A10AB01

ATC

insulin (human); parenteral

5.8

40.5

142

212

Kela drug reimbursment

Gout

10.2

40.4

WX002

NOMESCO Finland

Sedation and analgesia

2.9

40.3

246

1034

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.8

40.2

N02AA05

ATC

oxycodone; systemic

2.9

40.2

229

927

ZXE00

NOMESCO Finland

One hour or less

2.5

39.8

449

2541

UJF32

NOMESCO Finland

Coloscopy

2.6

39.7

315

1512

WX402

NOMESCO Finland

General anaesthesia

2.6

39.2

308

1470

Z3231

NOMESCO Finland

Registered nurse

2.6

39.1

335

1666

B01AB10

ATC

tinzaparin; parenteral

3.3

38.6

167

575

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

5.1

38.6

179

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

13.3

37.6

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

13.9

37.5

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.7

37.0

206

J05AB01

ATC

aciclovir; systemic

2.6

37.0

280

1307

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

36.9

406

2252

WX882

NOMESCO Finland

High dependency care

6.3

36.3

106

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

371.0

36.2

A02BC02

ATC

pantoprazole; systemic

2.7

36.1

718

5158

ZXA00

NOMESCO Finland

Right side

2.5

36.1

310

1535

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

49.9

35.9

C07AB02

ATC

metoprolol; systemic

2.8

35.9

220

921

J01FF01

ATC

clindamycin; systemic

2.5

35.7

329

1681

Z3226

NOMESCO Finland

Physiotherapist

2.7

35.6

237

1035

JJC00

NOMESCO Finland

Allogenic transplantation of liver

61.1

35.5

C02CA01

ATC

prazosin; oral

12.0

35.3

5AB14, ,

NOMESCO Finland

48.7

35.0

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

14.4

34.9

C09AA02

ATC

enalapril; systemic

2.8

34.8

221

941

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.6

34.7

125

382

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.0

34.6

108

299

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

59.6

34.5

N02AX02

ATC

tramadol; systemic, rectal

2.3

34.4

483

2953

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.6

34.1

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.5

33.7

213

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

7.1

33.4

JN6AD

NOMESCO Finland

CT of torso and neck

7.4

33.3

K83.0

ICD-10 Finland

Cholangitis

11.0

33.3

U14

ICPC

Kidney symptom/complaint

8.6

33.2

RD210, ,

NOMESCO Finland

8.1

33.0

SPAT1255

SPAT

Intravenous administration of medicine

3.9

32.8

103

286

A04AA01

ATC

ondansetron; systemic, rectal

3.4

32.3

127

410

A02BC01

ATC

omeprazole; systemic

2.4

32.3

303

1549

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

74.6

32.1

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

9.6

32.0

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

6.8

31.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

31.7

206

884

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

8.0

31.2

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.2

30.9

223

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.2

30.7

132

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.7

30.4

169

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.3

30.2

126

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.7

30.1

108

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

110.3

29.8

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

11.0

29.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.8

29.6

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.5

29.4

114

AA1AD

NOMESCO Finland

CT of head and brain

2.3

29.4

316

1702

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

9.5

29.3

K51.5

ICD-10 Finland

Left sided colitis

5.2

28.7

124

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

8.1

28.7

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

28.5

273

1396

A10AB04

ATC

insulin lispro; parenteral

5.0

28.2

130

A10AA01, ,

ATC

5.5

28.0

108

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

44.0

27.9

B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

27.2

TK810

NOMESCO Finland

Hemofiltration

24.7

27.2

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.4

27.0

168

XPX08

NOMESCO Finland

Intraoperative flow measurement

11.1

27.0

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

26.9

136

508

M10.9

ICD-10 Finland

Gout, unspecified

3.5

26.8

301

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

8.8

26.8

B02.9

ICD-10 Finland

Zoster without complication

3.5

26.7

100

312

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

9.4

26.6

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6.2

26.6

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

26.5

139

530

E87.5

ICD-10 Finland

Hyperkalaemia

7.4

26.4

C07AB07

ATC

bisoprolol; oral

2.1

26.3

472

3071

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

37.9

26.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.9

26.2

A03

ICPC

Fever

2.4

26.1

225

1094

C08CA05

ATC

nifedipine; systemic

3.9

26.1

218

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

41.4

26.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

25.9

170

727

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

74.9

25.9

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

74.9

25.9

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

22.6

25.8

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.2

25.8

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.1

25.8

119

422

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

8.4

25.8

N19

ICD-10 Finland

Unspecified kidney failure

4.8

25.5

129

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.2

25.3

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

25.3

447

2881

WZC30

NOMESCO Finland

Teaching

2.4

25.2

207

984

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.6

24.9

269

H05BX02

ATC

paricalcitol; systemic

256.6

24.8

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

25.1

24.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

24.5

219

1079

B01AB04

ATC

dalteparin; parenteral

4.1

24.5

181

H26.2

ICD-10 Finland

Complicated cataract

8.5

24.5

A10AA02, ,

ATC

4.8

24.3

126

B01AB05

ATC

enoxaparin; parenteral

2.1

24.1

325

1888

B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

+∞

24.1

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

21.3

24.0

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.5

23.9

271

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

5.0

23.9

112

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

128.3

23.7

Z2221

NOMESCO Finland

Medical doctor

2.1

23.6

298

1687

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

6.8

23.5

R11

ICD-10 Finland

Nausea and vomiting

2.9

23.5

120

450

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.7

23.4

230

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.0

23.4

A46

ICD-10 Finland

Erysipelas

2.5

23.2

172

778

3AC01, ,

NOMESCO Finland

19.1

23.2

A10AE04

ATC

insulin glargine; parenteral

2.8

23.1

127

495

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.3

23.1

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

9.3

23.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.8

23.0

125

484

C08CA13

ATC

lercanidipine; oral

2.5

23.0

165

735

M05BA04

ATC

alendronic acid; oral

3.2

23.0

315

J02AC03

ATC

voriconazole; systemic

30.9

22.9

ZXA05

NOMESCO Finland

Left side

2.2

22.8

251

1343

WX720

NOMESCO Finland

Own respiration

3.6

22.8

239

A12AA12

ATC

[U] calcium acetate

123.0

22.7

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

22.6

107

384

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

7.7

22.6

TPX15

NOMESCO Finland

Removal of vascular injection port

33.2

22.5

WW300

NOMESCO Finland

Transfer of autologic stem cells

33.2

22.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

22.5

557

3981

E83.50

ICD-10 Finland

Hypercalcemia

8.5

22.4

A07EA06

ATC

budesonide; oral, local oral

4.1

22.3

166

L03AA13

ATC

pegfilgrastim; parenteral

3.7

22.3

208

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

9.2

22.2

TAB00

NOMESCO Finland

Lumbar puncture

3.7

22.0

215

ZX112

NOMESCO Finland

Subcutaneous

5.4

21.9

WX203

NOMESCO Finland

Infraclavicular plexus blockade

5.1

21.3

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.7

21.2

111

A07EC02

ATC

mesalazine; oral, rectal

3.3

21.2

266

WX704

NOMESCO Finland

Intubation

2.9

21.0

110

417

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

61.5

21.0

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

20.8

237

1281

WW400

NOMESCO Finland

Plasmaferesis

78.6

20.8

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

8.4

20.6

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.1

20.5

264

1492

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

20.4

163

WW409

NOMESCO Finland

Other aferesis

33.4

20.3

A10AE05

ATC

insulin detemir; parenteral

3.4

20.3

242

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.7

20.2

183

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

27.7

20.1

NHQ40

NOMESCO Finland

Amputation of toe

6.9

20.1

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.9

20.0

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.2

20.0

B01AA03

ATC

warfarin; systemic

2.4

20.0

165

780

0785B

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[HEPATITIS CYTOMEGALICA]

+∞

19.9

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

+∞

19.9

A06AD11

ATC

lactulose; oral

2.4

19.8

147

662

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.5

19.8

210

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

18.2

19.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.7

19.6

177

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.3

19.6

Z94.2

ICD-10 Finland

Lung transplant status

41.0

19.6

M01AE01

ATC

ibuprofen; systemic, rectal

0.5

19.5

662

7771

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

19.5

113

452

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.1

19.3

292

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.8

19.2

105

407

Z94.1

ICD-10 Finland

Heart transplant status

26.7

19.2

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

18.7

19.2

C02EA02, ,

ATC

4.5

19.2

112

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.1

19.1

226

1234

SAA04

NOMESCO Finland

Special examination of mouth

3.2

19.0

273

SPAT1262

SPAT

Handing over of treatment supplies

2.2

18.9

183

923

WVA20

NOMESCO Finland

Medicine administration

4.3

18.9

122

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.8

18.9

158

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

6.7

18.8

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

71.4

18.8

B07.9

ICD-10 Finland

Verruca simplex

3.8

18.7

159

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.2

18.7

N05CF01

ATC

zopiclone; oral

1.9

18.6

317

1965

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

5.4

18.6

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

15.5

18.5

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

18.4

124

533

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

45.0

18.3

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

45.0

18.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

18.1

114

475

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.7

18.0

WX202

NOMESCO Finland

Supraclavicular plexus blockade

6.0

18.0

JJ5AT, ,

NOMESCO Finland

68.0

17.8

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.3

17.7

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

96.9

17.6

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

183.3

17.6

ED1AA

NOMESCO Finland

Mandibular X-ray examination

13.4

17.5

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.4

17.5

103

B59

ICD-10 Finland

Pneumocystosis

42.9

17.3

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.3

17.3

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

17.1

290

6BA02, ,

NOMESCO Finland

32.1

17.1

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

7.0

17.0

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.3

17.0

215

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

17.8

17.0

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

26.1

17.0

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.9

16.9

298

E86

ICD-10 Finland

Volume depletion

5.0

16.7

J01DB01

ATC

cefalexin; oral

2.2

16.7

798

6766

C10AA03

ATC

pravastatin; oral

2.9

16.6

289

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

16.6

361

2401

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

13.7

16.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

16.5

363

2420

3025

Kela drug reimbursment

Calcium carbonate

14.6

16.4

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

40.9

16.4

WX725

NOMESCO Finland

Noninvasive ventilation

3.0

16.3

264

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

16.3

103

429

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

7.2

16.2

Z51.5

ICD-10 Finland

Palliative care

2.7

16.1

364

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

11.9

16.1

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

16.1

159

806

153

Kela drug reimbursment

Lenalidomid

18.9

16.1

ZXA10

NOMESCO Finland

Bilateral

2.1

16.0

178

944

CKC12

NOMESCO Finland

Photocoagulation of retina

3.4

16.0

187

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.5

16.0

172

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

15.9

114

503

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

15.8

252

Z99.2

ICD-10 Finland

Dependence on renal dialysis

61.1

15.8

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

5.0

15.8

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

26.8

15.6

5BA08, ,

NOMESCO Finland

19.6

15.6

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

15.6

124

574

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.4

15.6

180

EBA10

NOMESCO Finland

Operative extraction of tooth

2.2

15.5

152

767

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

6.6

15.4

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

38.8

15.4

ZX197, ,

NOMESCO Finland

38.8

15.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

15.1

15.4

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.8

15.4

C08CA10

ATC

nilvadipine; oral

5.6

15.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.8

15.3

128

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

16.4

15.3

S97

ICPC

Chronic ulcer skin

2.8

15.2

303

T89

ICPC

Diabetes insulin dependent

3.1

15.2

214

L04AX04

ATC

lenalidomide; oral

18.1

15.2

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

18.1

15.2

JN4CD

NOMESCO Finland

Very extensive body CT

3.8

15.1

129

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.2

15.1

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

45.8

15.1

Y83.0

ICD-10 Finland

Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

45.8

15.1

GDG10

NOMESCO Finland

Bilateral transplantation of lung

45.8

15.1

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

15.1

217

1259

H02AB07

ATC

prednisone; oral

2.2

15.0

135

658

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

15.4

14.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

14.9

703

5781

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

6.9

14.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.1

14.9

217

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

32.3

14.8

G04CA02

ATC

tamsulosin; oral

1.9

14.8

217

1267

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.9

14.7

251

329

Kela drug reimbursment

Lenalidomide

25.5

14.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.8

14.7

291

WX204

NOMESCO Finland

Axillary plexus blockaced

3.4

14.7

166

J02AC01

ATC

fluconazole; systemic

1.8

14.7

356

2423

B27.0

ICD-10 Finland

Gammaherpesviral mononucleosis

+∞

14.6

XQ845

NOMESCO Finland

Dermatoscopy

5.1

14.6

A28

ICPC

Limited function/disability NOS

2.1

14.6

155

806

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.7

14.5

128

187

Kela drug reimbursment

MPA

152.3

14.5

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

36.7

14.5

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.4

14.5

102

447

M05BX04

ATC

denosumab; parenteral

3.0

14.4

221

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.5

14.4

UJF92

NOMESCO Finland

Capsular endoscopy

4.5

14.4

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

14.3

278

L04AA05

ATC

[U] tacrolimus

43.2

14.1

K65.9

ICD-10 Finland

Peritonitis, unspecified

43.2

14.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

14.1

127

618

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.0

14.1

C09CA01

ATC

losartan; oral

1.8

14.0

246

1518

UKC02

NOMESCO Finland

Cystoscopy

2.1

14.0

150

782

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

16.1

14.0

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

5.7

13.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.4

13.9

157

R18

ICD-10 Finland

Ascites

4.8

13.8

WX610

NOMESCO Finland

Patient controlled analgesia

11.6

13.8

YNB10

NOMESCO Finland

Collection of stem cells for transplant

54.2

13.8

RJ410, ,

NOMESCO Finland

20.4

13.8

H02AB02

ATC

dexamethasone; systemic

2.2

13.8

125

610

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.4

13.8

1511

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.7

13.7

284

L01BB02

ATC

mercaptopurine; oral

5.8

13.7

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

5.8

13.7

R31

ICD-10 Finland

Unspecified haematuria

2.3

13.7

107

491

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

13.6

315

7151

FHL

Kidney transplantation

76.3

13.6

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

+∞

13.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

13.5

409

WX199

NOMESCO Finland

Other local analgesia

3.6

13.5

125

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

142.0

13.5

J05AX18

ATC

letermovir; oral

142.0

13.5

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.7

13.4

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

13.4

124

610

HA1AA

NOMESCO Finland

X-ray mammography

2.5

13.4

373

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.9

13.4

107

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

13.3

231

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

40.7

13.2

N25.0

ICD-10 Finland

Renal osteodystrophy

40.7

13.2

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

12.4

13.1

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.3

13.1

163

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

10.2

13.0

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

28.8

13.0

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

28.8

13.0

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.2

13.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.2

13.0

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.2

13.0

115

556

GD2SN

NOMESCO Finland

Lung ventilation SPECT

13.2

13.0

K06.18

ICD-10 Finland

Another gingival hyperplasia

19.4

12.9

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.8

12.9

105

I50.0

ICD-10 Finland

Congestive heart failure

2.8

12.9

235

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.9

12.8

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.8

12.8

A12BA01

ATC

potassium chloride; oral

3.8

12.8

106

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

12.7

140

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

4.9

12.7

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

5.6

12.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

12.6

221

WX140

NOMESCO Finland

Parabulbar anesthesy

3.0

12.6

188

XF612

NOMESCO Finland

Measurement of central venous pressure

32.5

12.6

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

+∞

12.5

5AD01, ,

NOMESCO Finland

+∞

12.5

XF602

NOMESCO Finland

Bloodpressure monitoring

6.3

12.5

K65.8

ICD-10 Finland

Other peritonitis

24.7

12.5

E21.2

ICD-10 Finland

Other hyperparathyroidism

20.4

12.5

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.6

12.5

122

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

13.4

12.5

58209

ICD-8 Finland

Chronic nephritis, Unspecified

131.7

12.5

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.1

12.5

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

12.4

281

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.8

12.4

XQ848

NOMESCO Finland

Dermatological photography

3.7

12.4

113

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

11.8

12.4

RJ411, ,

NOMESCO Finland

11.8

12.4

A04AA02

ATC

granisetron; systemic, transdermal

2.6

12.3

307

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.2

12.3

159

M01AH05

ATC

etoricoxib; oral

0.6

12.2

373

4892

D64.8

ICD-10 Finland

Other specified anaemias

5.0

12.2

K51.8

ICD-10 Finland

Other ulcerative colitis

4.6

12.2

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

16.1

12.2

ZX100

NOMESCO Finland

Oral

5.6

12.2

B01AF02

ATC

apixaban; oral

2.1

12.2

120

605

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

12.6

12.2

1XC02, ,

NOMESCO Finland

12.6

12.2

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

12.1

226

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.9

12.1

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.5

12.0

120

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.4

12.0

130

RS221, ,

NOMESCO Finland

5.1

12.0

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.9

12.0

180

1052

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.8

12.0

K50.8

ICD-10 Finland

Other Crohn disease

4.5

12.0

GD1LA

NOMESCO Finland

4.9

12.0

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

47.3

11.9

J01CA04

ATC

amoxicillin; systemic

1.9

11.9

777

6751

WX730

NOMESCO Finland

Conventional respirator

5.5

11.9

J96.0

ICD-10 Finland

Acute respiratory failure

5.5

11.9

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.9

11.8

ZX121

NOMESCO Finland

Central venous catheter

14.9

11.8

M10.3

ICD-10 Finland

Gout due to impairment of renal function

16.7

11.7

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.6

11.7

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

30.4

11.7

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.0

11.6

H3603, E107,

ICD-10 Finland

65.8

11.6

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

65.8

11.6

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

65.8

11.6

KAC00

NOMESCO Finland

Nephrectomy

19.2

11.6

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

23.2

11.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.6

11.6

273

H36.01

ICD-10 Finland

Diabetic maculopathy

5.1

11.5

0785X

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[VIROSIS ALIA CYTOMEGALICA]

+∞

11.5

N03AX16

ATC

[U] pregabalin

1.8

11.5

219

1376

JAH01

NOMESCO Finland

Laparoscopy

3.0

11.4

177

K76.9

ICD-10 Finland

Liver disease, unspecified

5.5

11.4

SBA00

NOMESCO Finland

Microbiological examinations

3.8

11.4

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

11.3

102

496

L01AA01

ATC

cyclophosphamide; systemic

17.3

11.2

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

25.4

11.2

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

20.3

11.2

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

20.3

11.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

11.1

181

1083

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.9

11.0

J02AC04

ATC

posaconazole; systemic

43.9

10.9

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

43.9

10.9

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

43.9

10.9

JAH00

NOMESCO Finland

Laparotomy

3.4

10.9

118

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.5

10.9

294

I15.0

ICD-10 Finland

Renovascular hypertension

15.7

10.9

N30.0

ICD-10 Finland

Acute cystitis

1.9

10.8

146

824

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

10.7

223

L04AA10

ATC

[U] sirolimus

28.4

10.7

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

28.4

10.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.4

10.7

327

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

10.7

321

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.0

10.7

156

XX3ZW, ,

NOMESCO Finland

60.7

10.6

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

60.7

10.6

J12.8

ICD-10 Finland

Other viral pneumonia

8.1

10.6

H3601, E103,

ICD-10 Finland

8.6

10.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.4

10.6

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.6

10.5

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.9

10.5

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.9

10.5

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

10.5

126

R06.0

ICD-10 Finland

Dyspnoea

1.7

10.5

248

1649

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

10.5

244

1616

C03AA03

ATC

hydrochlorothiazide; oral

2.4

10.4

331

KAS40

NOMESCO Finland

Excision of transplanted kidney

111.2

10.4

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.2

10.4

137

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

+∞

10.4

ZY010

NOMESCO Finland

Hospital outpatient

2.5

10.4

263

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

10.4

181

204

Kela drug reimbursment

Leukemia lymphatica

3.5

10.4

102

RJ421, ,

NOMESCO Finland

16.2

10.4

RJ420, ,

NOMESCO Finland

12.2

10.4

L28

ICPC

Limited function/disability (L)

1.8

10.4

159

933

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.0

10.4

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

4.4

10.4

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

32.9

10.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

32.9

10.3

SPAT1263

SPAT

Sampling

1.6

10.3

368

2708

XF402

NOMESCO Finland

ECG with work load test

2.1

10.3

494

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

23.7

10.3

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

23.7

10.3

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

23.7

10.3

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.4

10.1

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

10.1

248

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

10.1

196

1233

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

40.5

10.0

L57.0

ICD-10 Finland

Actinic keratosis

2.1

10.0

486

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

9.9

100

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

9.9

275

E000001, ,

ATC

1.8

9.8

182

1129

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

26.3

9.8

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

26.3

9.8

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.9

9.8

164

A08.3

ICD-10 Finland

Other viral enteritis

20.3

9.8

R4180

NOMESCO Finland

Podiatric therapy

4.6

9.8

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.6

9.8

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.3

9.8

116

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

9.8

239

1598

E0000UV, ,

ATC

1.6

9.8

378

2825

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.3

9.7

ZX196, ,

NOMESCO Finland

55.6

9.7

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

5.1

9.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

9.6

189

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.7

9.6

195

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.7

9.5

207

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

10.2

9.5

N0832, E102,

ICD-10 Finland

101.0

9.4

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

9.4

393

TPH00

NOMESCO Finland

Phlebotomy

17.7

9.4

58399

ICD-8 Finland

Nephritis, unqualified

+∞

9.4

07959

ICD-8 Finland

Other viral diseases, Virosis cytomegalica NUD

+∞

9.4

GD1UN

NOMESCO Finland

Lung circulation SPECT

12.5

9.4

K72.9

ICD-10 Finland

Hepatic failure, unspecified

12.5

9.4

1CX01, ,

NOMESCO Finland

21.9

9.4

120

Kela drug reimbursment

Hypogammaglobulinaemia

21.9

9.4

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

9.3

171

1056

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

8.8

9.3

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

8.8

9.3

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

10.8

9.3

J96.1

ICD-10 Finland

Chronic respiratory failure

4.1

9.3

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.1

9.3

478

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

13.8

9.2

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

9.2

298

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.7

9.2

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.4

9.1

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

8.4

9.1

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

11.6

9.1

K74.3

ICD-10 Finland

Primary biliary cirrhosis

11.6

9.1

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

7.1

9.1

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

9.2

9.1

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

15.8

9.0

I50.1

ICD-10 Finland

Left ventricular failure

2.8

9.0

166

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.2

9.0

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

10.2

9.0

RJ120, ,

NOMESCO Finland

37.1

9.0

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.3

9.0

XX4BW, ,

NOMESCO Finland

18.8

8.9

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

8.9

267

1872

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

24.3

8.9

R04.0

ICD-10 Finland

Epistaxis

2.2

8.9

348

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

8.9

225

1514

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

8.9

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.7

8.9

K12.18

ICD-10 Finland

Other forms of stomatitis

10.8

8.8

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

10.8

8.8

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

8.8

234

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

8.8

184

1179

D11AH01

ATC

tacrolimus; topical

7.3

8.8

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

8.7

109

KA3EB

NOMESCO Finland

Antegrade pyelography

14.2

8.7

V03AG01

ATC

sodium cellulose phosphate; systemic

50.5

8.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

8.6

346

J94.8

ICD-10 Finland

Other specified pleural conditions

4.8

8.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.3

8.6

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

11.7

8.6

R80

ICD-10 Finland

Isolated proteinuria

9.1

8.6

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

10.2

8.5

XQ902

NOMESCO Finland

Other photography

6.5

8.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

8.5

481

3865

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.2

8.5

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.9

8.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

8.5

283

H30.1

ICD-10 Finland

Disseminated chorioretinal inflammation

90.8

8.4

L04AH02

ATC

everolimus; oral

90.8

8.4

N0830, E102,

ICD-10 Finland

90.8

8.4

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.4

8.4

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

8.0

8.4

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

8.4

132

779

B25

ICD-10 Finland

Cytomegaloviral disease

+∞

8.3

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

+∞

8.3

KA2DE, ,

NOMESCO Finland

+∞

8.3

PBU81

NOMESCO Finland

Thrombectomy in arteriovenous fistula from artery of upper extremity

+∞

8.3

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

+∞

8.3

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

+∞

8.3

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

10.9

8.3

S18

ICPC

Laceration/cut

1.5

8.3

427

3360

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.9

8.3

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.9

8.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

8.3

352

2663

H26.4

ICD-10 Finland

After-cataract

2.1

8.2

387

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

6.6

8.2

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

6.6

8.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

8.2

536

N02BE01

ATC

paracetamol; systemic, rectal

1.8

8.2

818

7425

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

8.2

187

1225

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.6

8.1

H3603, E113,

ICD-10 Finland

8.2

8.1

A10AD01

ATC

insulin (human); parenteral

4.1

8.1

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

8.1

104

575

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

11.8

8.1

B73

ICPC

Leukaemia

33.7

8.1

Q61.0

ICD-10 Finland

Congenital single renal cyst

33.7

8.1

C83.00

ICD-10 Finland

Lymphocytic lymphoma

33.7

8.1

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

33.7

8.1

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

17.3

8.1

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

17.3

8.1

306

Kela drug reimbursment

Erythropoietin and darbepoetin

17.3

8.1

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

10.1

8.0

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.4

8.0

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

22.2

8.0

WX400

NOMESCO Finland

Inhalation anesthesy

2.5

8.0

195

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.6

8.0

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.6

8.0

C10AA01

ATC

simvastatin; oral

1.5

8.0

315

2340

A01AB09

ATC

miconazole; local oral

2.1

7.9

372

RS222, ,

NOMESCO Finland

4.7

7.9

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

13.2

7.9

C03DA01

ATC

spironolactone; oral

1.9

7.9

104

580

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.2

7.9

325

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

8.5

7.8

NGQ20

NOMESCO Finland

Amputation of lower leg

8.5

7.8

C10AA04

ATC

fluvastatin; oral

2.1

7.8

360

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

10.9

7.8

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

7.0

7.8

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

7.0

7.8

SPAT1254

SPAT

Administration of medicine

1.8

7.8

122

719

A40.8

ICD-10 Finland

Other streptococcal sepsis

6.4

7.7

B74

ICPC

Malignant neoplasm blood other

45.4

7.7

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

45.4

7.7

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

45.4

7.7

N083, E102,

ICD-10 Finland

45.4

7.7

KAS70

NOMESCO Finland

Inspection and preparation of kidney, pre-transplantation

45.4

7.7

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.3

7.7

ZX120, ,

SPAT

4.4

7.7

CKC15

NOMESCO Finland

Panretinal photocoagulation

8.1

7.6

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

18.5

7.6

RJ210, ,

NOMESCO Finland

18.5

7.6

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.8

7.6

ZXC50

NOMESCO Finland

Cryotherapy

3.0

7.6

113

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

12.0

7.6

K75.4

ICD-10 Finland

Autoimmune hepatitis

25.2

7.6

UJK02

NOMESCO Finland

ERCP

3.3

7.6

C09AA05

ATC

ramipril; oral

1.6

7.6

206

1406

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

7.2

7.5

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.0

7.5

394

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.7

7.5

154

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

7.4

367

742, ,

NOMESCO Finland

80.7

7.4

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

80.7

7.4

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

80.7

7.4

L01BB01, ,

ATC

80.7

7.4

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.7

7.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

7.4

293

L01AA02

ATC

chlorambucil; oral

13.5

7.4

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.8

7.4

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

4.1

7.4

R53

ICD-10 Finland

Malaise and fatigue

1.6

7.4

220

1534

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

8.4

7.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

7.3

328

B01AC04

ATC

clopidogrel; oral

1.7

7.3

131

802

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

11.0

7.3

UJF02

NOMESCO Finland

Peroral enteroscopy

11.0

7.3

J05AX10, ,

ATC

+∞

7.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

7.3

9811/3-C42.1

ICD-O-3

B lymphoblastic leukemia/lymphoma, NOS, of bone marrow

+∞

7.3

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

7.3

L04AA18

ATC

[U] everolimus

+∞

7.3

474, ,

NOMESCO Finland

+∞

7.3

D638, N180,

ICD-10 Finland

+∞

7.3

0750X

ICD-9 Finland

Infectious mononucleosis[MONONUCLEOSIS INFECTIOSA SINE COMPLICATIONE]

+∞

7.3

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

+∞

7.3

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.2

7.3

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.9

7.3

SPAT1301

SPAT

No procedures

1.5

7.3

252

1815

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

6.3

7.3

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.6

7.3

168

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

7.2

243

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

7.2

111

K81.0

ICD-10 Finland

Acute cholecystitis

3.7

7.2

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

7.2

330

E83.51

ICD-10 Finland

Hypocalcemia

7.4

7.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

7.2

151

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

30.3

7.2

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

30.3

7.2

WW402

NOMESCO Finland

Leucoferesis

30.3

7.2

3A422, ,

NOMESCO Finland

30.3

7.2

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

30.3

7.2

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

20.2

7.1

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

7.1

271

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

8.0

7.1

C08DB01

ATC

diltiazem; oral

2.6

7.1

158

H3600, E103,

ICD-10 Finland

5.7

7.1

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.0

7.1

107

K01.0

ICD-10 Finland

Embedded teeth

3.7

7.1

D07AB08

ATC

desonide; topical

1.8

7.0

102

586

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

10.1

7.0

L73.8

ICD-10 Finland

Other specified follicular disorders

4.2

7.0

J01CA08

ATC

pivmecillinam; oral

1.5

7.0

301

2264

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

7.0

270

1989

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.4

7.0

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.7

6.9

142

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

13.9

6.9

D07AA02

ATC

hydrocortisone; topical

1.7

6.9

133

831

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.2

6.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

6.9

115

690

A02BC05

ATC

esomeprazole; systemic

1.5

6.9

350

2721

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

4.2

6.8

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

6.8

C83.1

ICD-10 Finland

Mantle cell lymphoma

11.0

6.8

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

11.0

6.8

J80

ICD-10 Finland

Adult respiratory distress syndrome

9.4

6.8

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.9

6.8

104

A01AB04

ATC

amphotericin B; local oral

2.5

6.8

174

2AX04, ,

NOMESCO Finland

40.3

6.8

N08.30

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

40.3

6.8

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

40.3

6.8

253, ,

Kela drug reimbursment

16.8

6.8

3A064, ,

NOMESCO Finland

16.8

6.8

3042, ,

Kela drug reimbursment

16.8

6.8

L04AX06

ATC

pomalidomide; oral

16.8

6.8

A10BH02

ATC

vildagliptin; oral

3.9

6.7

N43.3

ICD-10 Finland

Hydrocele, unspecified

3.3

6.7

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

6.7

573

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

22.7

6.7

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.1

6.6

TQW80

NOMESCO Finland

Local dermatologic skincare

3.0

6.6

100

602

Kela drug reimbursment

Children's severe malnutrition

7.9

6.6

C10AA05

ATC

atorvastatin; oral

1.4

6.6

348

2716

AN1

Coronary angiography

1.9

6.6

441

N02AC04

ATC

dextropropoxyphene; oral

2.8

6.6

117

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

12.3

6.6

WX740

NOMESCO Finland

Nitrogen oxide therapy

12.3

6.6

M01AC06

ATC

meloxicam; systemic, rectal

0.6

6.6

169

2412

SPAT1325

SPAT

Vaccination

1.5

6.6

259

1912

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.4

6.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

6.5

124

K83.1

ICD-10 Finland

Obstruction of bile duct

4.0

6.5

L03AA14

ATC

lipegfilgrastim; parenteral

3.3

6.4

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

70.3

6.4

2AX05, ,

NOMESCO Finland

70.3

6.4

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

70.3

6.4

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

70.3

6.4

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

70.3

6.4

B34.8

ICD-10 Finland

Other viral infections of unspecified site

70.3

6.4

TFJ02

NOMESCO Finland

Muscle biopsy of heart

14.4

6.4

RJ190, ,

NOMESCO Finland

14.4

6.4

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

4.1

6.4

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

4.1

6.4

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

6.4

339

2648

K12.10

ICD-10 Finland

Stomatitis NOS

8.2

6.3

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.2

6.3

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

6.3

106

636

L84

ICD-10 Finland

Corns and callosities

2.6

6.3

143

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.2

6.3

N18

ICD-10 Finland

Chronic kidney disease

6.0

6.3

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.3

6.3

M34.1

ICD-10 Finland

CR(E)ST syndrome

11.1

6.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

11.1

6.3

SPAT1153

SPAT

Removal of sutures

1.5

6.3

257

1907

B72

ICPC

Hodgkin Lymphoma

18.2

6.3

390

Kela drug reimbursment

Ibrutinib

18.2

6.3

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

6.3

252

SPAT1229

SPAT

Assessment of need for aid

2.1

6.3

279

07951

ICD-8 Finland

Other viral diseases, Virosis cytomegalica asquisita

+∞

6.3

C92.5

ICD-10 Finland

Acute myelomonocytic leukaemia

+∞

6.3

JLE70

NOMESCO Finland

Inspection and preparation of pancreas, pre-transplantation

+∞

6.3

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

6.3

RJ530, ,

NOMESCO Finland

+∞

6.3

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

+∞

6.3

H30.0

ICD-10 Finland

Focal chorioretinal inflammation

+∞

6.3

9968A

ICD-9 Finland

Complications peculiar to certain specified procedures, Complications of transplanted organ

+∞

6.3

B95.6

ICD-10 Finland

Staphylococcus aureus as the cause of diseases classified to other chapters

+∞

6.3

07997

ICD-8 Finland

Other viral diseases, Viroses suspectae

+∞

6.3

H25.8

ICD-10 Finland

Other senile cataract

1.9

6.2

406

RJ422, ,

NOMESCO Finland

26.9

6.2

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.0

6.2

C09CA06

ATC

candesartan; oral

1.5

6.2

211

1509

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

6.2

301

R06AE07

ATC

cetirizine; oral

1.4

6.2

375

2996

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.8

6.2

C02EA01, ,

ATC

7.7

6.1

L01XX05

ATC

hydroxycarbamide; oral

4.2

6.1

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

12.6

6.1

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

12.6

6.1

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

12.6

6.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

6.1

395

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

3.6

6.1

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

6.7

6.0

C02DE02, ,

ATC

6.7

6.0

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

10.1

6.0

N03AX14

ATC

levetiracetam; systemic

2.7

6.0

117

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.9

6.0

100

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.5

6.0

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.5

6.0

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

5.2

6.0

K02.1

ICD-10 Finland

Caries of dentine

1.4

6.0

543

4637

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.6

6.0

135

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020779) Urea [Moles/volume] in Serum or Plasma

466

742

11.48

313.29

35.9

7.6

12.81

9.02

mmol/l

19.82

459

713

(3048929) Epstein Barr virus Ab [Presence] in Serum

367

316

18.42

307.65

1.8

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

383

198

31.98

307.65

2.4

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

261

87.78

307.65

46.9

36.3

7.41

6.54

ug/l

2.50

236

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

359

185

30.80

307.65

2.4

1.6

125.87

146.79

au/ml

1.20

115

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

448

158

53.31

307.65

5.8

3.9

6018.56

1452.42

u/ml

0.42

(3010375) cycloSPORINE [Mass/volume] in Blood

201

77.23

307.65

39.0

37.4

122.69

141.89

ug/l

0.67

168

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

241

114

28.09

307.65

2.5

2.4

19.10

25.26

iu/ml

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

241

108

29.67

307.65

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

546

200

63.84

307.65

21.1

5.9

3818.11

350.58

iu/ml

1.06

322

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

340

200

26.08

307.65

1.8

1.4

256.02

251.23

u/ml

0.07

229

116

(3003458) Phosphate [Moles/volume] in Serum or Plasma

546

1112

10.34

295.86

32.8

6.3

1.12

1.04

mmol/l

7.05

536

1040

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

201

31.30

294.56

1.6

1.4

53.52

88.17

—

(40768446) Kidney Pathology biopsy report

164

60.00

289.87

2.5

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

476

909

9.59

269.40

13.2

5.0

275.53

243.58

u/l

3.56

467

870

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

260

241

14.54

253.94

3.9

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

255

233

14.65

251.17

3.6

1.8

—

(3042733) HLA Ab [Presence] in Serum

146

50.66

249.37

5.8

4.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

350

561

9.35

226.57

3.5

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

269

328

11.09

215.97

3.3

1.9

1.45

1.53

g/l

0.56

247

290

(3024471) HLA-A [Type]

126

50.03

215.20

1.0

—

(3024932) HLA-DR beta [Type]

126

50.03

215.20

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

383

720

8.29

214.02

6.8

2.7

8.67

10.49

g/l

10.69

370

670

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

130

42.95

213.75

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

222

235

12.06

196.38

4.7

5.1

0.26

0.39

iu/ml

3.90

116

122

(3023368) Bacteria identified in Blood by Culture

652

2210

7.38

196.04

13.4

4.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

500

1328

6.91

195.60

4.7

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

449

1090

6.98

192.62

3.4

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

110

54.04

191.47

1.2

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

429

1005

7.02

190.69

3.6

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

353

681

7.70

190.26

7.6

2.9

72.91

72.46

e9/l

0.06

259

492

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

457

1153

6.77

187.52

9.1

2.6

23.58

23.41

0.09

448

1084

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

201

197

12.71

186.96

2.6

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

326

588

7.96

186.89

15.2

4.4

183.78

82.11

ng/l

21.23

314

530

(3012095) Magnesium [Moles/volume] in Serum or Plasma

507

1423

6.57

185.04

14.9

3.9

0.79

0.82

mmol/l

8.01

494

1358

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

412

956

6.90

184.09

3.7

1.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

469

1246

6.52

181.06

9.0

2.5

2.07

2.34

g/l

21.98

458

1164

(3027945) Reticulocytes/Erythrocytes in Blood

394

895

6.86

179.38

8.1

2.8

2.09

1.80

4.30

384

815

(3022948) Iron [Moles/volume] in Serum or Plasma

478

1336

6.25

173.23

9.0

2.6

12.12

13.65

umol/l

4.82

468

1251

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

176

160

13.31

171.38

4.3

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

480

1380

6.07

167.55

3.4

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

307

580

7.38

166.85

2.8

1.6

1.28

1.27

g/l

0.04

281

539

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

199

230

10.71

164.10

2.1

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

156

129

14.30

160.75

2.7

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

156

129

14.30

160.75

2.7

1.7

—

(44790049) Parainfluenza type 3 nucleic acid detection

156

129

14.30

160.75

2.7

1.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

156

129

14.30

160.75

2.7

1.7

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

130

18.47

156.23

2.4

1.8

—

(3011412) CD3 cells [#/volume] in Blood

131

17.75

154.22

4.5

2.0

1398.92

1235.15

e6/l

0.56

118

(3012544) pH of Venous blood

356

845

6.17

151.72

17.0

4.3

7.36

7.38

5.12

275

477

(46235355) HIV 1 and 2 tests - Meaningful Use set

512

1673

5.53

150.80

3.4

1.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

167

11.86

150.61

2.5

1.7

—

(3002032) Base excess in Venous blood by calculation

346

810

6.18

149.44

17.6

4.3

0.70

1.88

mmol/l

6.67

302

704

(3021879) Hepatitis B virus core Ab [Presence] in Serum

330

741

6.32

149.01

2.3

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

144

121

13.88

146.61

3.0

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

143

121

13.76

144.93

2.8

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

348

844

5.96

144.01

17.4

4.2

5.76

5.83

kpa

0.59

337

824

(3014148) Varicella zoster virus Ab [Titer] in Serum

144

125

13.43

143.63

1.2

—

(42870588) Differential panel, method unspecified - Blood

671

2848

5.75

140.70

24.1

6.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

146

134

12.72

140.50

2.5

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

198

279

8.73

138.70

5.0

3.3

3.13

3.65

g/l

3.41

192

271

(3018677) aPTT in Platelet poor plasma by Coagulation assay

424

1258

5.32

138.12

5.1

2.6

29.35

29.38

0.03

417

1222

(3002179) Metamyelocytes/Leukocytes in Blood

314

719

6.06

137.78

11.4

4.8

0.72

0.52

1.20

247

215

(3017181) Myelocytes/Leukocytes in Blood

321

753

5.96

137.11

11.6

4.8

0.83

0.86

0.11

253

234

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

157

167

11.09

136.63

2.4

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

109

19.14

134.44

5.2

2.2

199.36

197.80

e6/l

0.02

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

209

326

7.96

133.86

3.4

2.0

1.62

2.13

ug/l

0.22

197

295

(3042111) Morphology [Interpretation] in Bone marrow Narrative

139

129

12.47

132.61

3.2

1.9

—

(3042936) Bacteria identified in Isolate by Culture

409

1218

5.18

131.66

3.6

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

34.92

129.86

4.3

2.5

0.59

0.61

mmol/l

0.44

(3018418) pH of Serum or Plasma

591

2374

5.02

129.52

25.4

4.1

7.39

7.40

2.06

522

1705

(3026493) Urate [Moles/volume] in Serum or Plasma

563

2183

4.94

129.06

9.9

2.8

368.36

343.41

umol/l

5.37

546

1951

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

103

19.16

127.40

3.6

2.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

132

130

11.65

120.78

8.3

6.6

11.40

10.80

mg/l

0.62

121

118

(3024561) Albumin [Mass/volume] in Serum or Plasma

724

3538

5.57

119.99

28.4

5.1

33.93

36.16

g/l

22.63

704

3345

(3004809) Band form neutrophils/Leukocytes in Blood

127

123

11.78

117.45

9.3

3.7

1.32

1.72

0.42

121

117

(3000850) Epithelial cells [#/volume] in Urine

490

1808

4.58

117.24

9.3

2.6

3.37

5.47

e6/l

3.41

477

1647

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

17.45

117.10

4.8

2.1

850.35

478.42

e6/l

2.27

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

183

284

7.76

117.03

4.0

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

148

187

9.21

112.50

2.2

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

264

629

5.45

108.50

6.5

2.9

62.15

67.07

g/l

14.54

252

588

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

15.96

106.31

3.5

2.5

31.36

40.41

2.07

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

705

3594

4.86

104.45

37.8

7.3

1.21

mmol/l

0.08

697

3345

(4035726) Immunohistochemistry procedure

278

720

5.06

103.10

2.4

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

586

2651

4.22

101.70

12.3

3.2

30.14

74.57

e6/l

1.03

530

2008

(3026782) Osmolality of Urine

422

1525

4.21

100.84

10.2

2.7

464.15

535.35

mosm/kgh2o

13.84

405

1338

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

101

12.89

100.46

4.6

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

106

100

11.82

99.42

4.5

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

226

505

5.58

99.27

13.2

3.4

109.32

130.71

g/l

35.71

216

494

(3019069) Monocytes/Leukocytes in Blood

742

4017

5.04

99.10

27.0

7.0

8.82

8.86

0.12

736

3787

(36304419) Bacteria [Presence] in Urine

519

2188

4.07

99.03

10.3

3.1

—

0.00

estimate

—

(3022096) Basophils/Leukocytes in Blood

740

4007

5.00

98.56

26.6

7.0

0.61

0.69

3.66

734

3771

(3006504) Eosinophils/Leukocytes in Blood

740

4008

4.99

98.50

26.5

6.9

2.20

2.90

17.30

734

3772

(3030467) Casts [#/volume] in Urine by Automated count

532

2295

4.04

97.85

11.5

3.1

0.29

0.40

e6/l

0.44

464

1658

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

735

3993

4.87

96.56

50.6

7.8

1.21

mmol/l

0.07

690

3481

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

288

808

4.70

96.07

5.1

3.1

—

(3006315) Basophils [#/volume] in Blood

771

4365

5.28

95.20

23.3

6.8

0.04

e9/l

7.65

724

3756

(3001604) Monocytes [#/volume] in Blood

770

4359

5.26

94.98

23.4

6.8

0.60

0.58

e9/l

1.57

724

3744

(3033658) Prothrombin time (PT) actual/Normal

497

2099

3.91

93.15

13.6

4.4

94.86

90.92

2.92

492

2065

(3019198) Lymphocytes [#/volume] in Blood

774

4446

5.22

92.36

23.8

6.9

2.06

1.99

e9/l

0.13

733

3928

(3021440) Promyelocytes/Leukocytes in Blood

266

721

4.75

92.35

12.5

4.9

0.09

0.12

0.59

200

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

242

609

5.01

92.06

10.8

4.6

4.87

5.15

kpa

6.64

235

595

(3024354) Oxygen [Partial pressure] in Venous blood

267

731

4.71

91.45

13.1

3.8

5.68

4.59

kpa

9.60

261

714

(3025159) Blasts/Leukocytes in Blood

267

731

4.71

91.45

12.6

5.3

0.39

0.18

0.30

202

181

(3009343) pH of Capillary blood

238

596

5.01

91.00

10.7

4.7

7.41

7.42

1.98

211

498

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

249

650

4.85

90.44

6.9

2.5

40.66

71.63

ml/min/173m2

23.70

134

272

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

170

317

6.33

90.20

2.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

102

105

10.78

89.95

1.9

1.4

—

(3013115) Eosinophils [#/volume] in Blood

774

4501

5.10

89.37

25.5

7.2

0.15

0.19

e9/l

12.75

730

3936

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

373

1334

3.98

88.49

7.8

3.0

1.89

2.07

e6/l

0.18

231

640

(3011648) Oxygen content in Venous blood

10.81

85.99

10.0

3.9

11.11

10.41

0.79

(3018095) Leukocytes [#/volume] in Urine

607

3039

3.82

85.65

15.0

3.9

139.55

89.41

e6/l

0.48

544

2110

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

386

1446

3.83

84.97

7.0

2.9

0.66

1.02

e6/l

1.51

246

751

(3037756) Immunofixation for Serum or Plasma

119

163

8.21

83.99

3.4

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

214

524

4.99

83.58

10.4

4.8

1.01

1.77

mmol/l

2.03

157

398

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

144

245

6.76

83.46

7.7

3.5

42.34

40.03

mg/l

0.10

120

213

(3016502) Oxygen saturation in Arterial blood

276

826

4.32

83.42

15.6

10.3

94.64

95.73

1.66

263

801

(3034860) Kappa light chains.free [Mass/volume] in Serum

144

246

6.73

83.12

7.7

3.5

72.50

72.28

mg/l

0.00

120

214

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

304

980

4.11

82.90

12.7

3.0

9.46

8.44

umol/l

0.34

280

878

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

550

2633

3.63

82.13

8.0

2.6

54.82

62.21

u/l

1.83

531

2452

(3037692) Legionella sp identified in Specimen by Organism specific culture

19.32

81.78

2.0

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

208

506

5.00

81.76

6.0

2.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

466

2023

3.59

80.97

3.7

2.2

2.92

2.84

mg/l

0.30

430

1745

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

45.93

80.90

10.0

5.0

5.15

5.68

mmol/l

0.47

(3032080) INR in Blood by Coagulation assay

667

3638

3.88

80.60

25.7

12.0

1.18

1.20

inr

0.45

598

2989

(3007853) Bacteria identified in Skin by Aerobe culture

303

993

4.03

80.45

2.5

1.7

—

(1616796) Gas panel - Central venous blood

118

170

7.80

79.64

9.9

3.2

—

(3019977) pH of Arterial blood

287

926

4.02

77.59

16.0

9.8

7.42

7.41

0.27

159

500

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

111

9.52

77.54

1.7

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

133

225

6.72

77.33

7.3

3.3

8.54

2.37

ratio

1.05

132

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

287

931

4.00

76.93

16.0

9.7

4.88

5.16

kpa

5.35

273

904

(3027801) Oxygen [Partial pressure] in Arterial blood

287

931

4.00

76.93

16.0

9.7

11.59

12.48

kpa

2.31

271

905

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

143

264

6.21

76.17

2.4

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

780

4826

4.64

76.02

38.1

10.3

4.00

4.04

e9/l

0.18

740

4194

(3008536) Aspergillus sp Ab [Presence] in Serum

27.47

75.63

4.2

1.5

—

(3000494) Fungus identified in Specimen by Culture

313

1089

3.81

75.62

3.2

1.5

—

(3003396) Base excess in Arterial blood by calculation

280

917

3.93

73.69

15.8

9.8

-0.36

0.96

mmol/l

5.74

233

775

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

130

226

6.52

73.49

2.3

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

109

157

7.72

73.44

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

251

780

4.03

70.93

17.4

10.7

108.24

122.29

g/l

20.07

241

765

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

106

156

7.53

70.00

15.8

2.7

15.76

8.35

pmol/l

5.25

106

156

(3020876) Protein [Mass/time] in 24 hour Urine

9.91

69.64

3.7

2.3

1.79

1.25

g/24h

0.72

(3000093) Morphology [Interpretation] in Blood Narrative

11.07

67.56

1.6

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

34.62

67.36

2.4

2.3

—

(3026008) Bacteria identified in Urine by Culture

461

2175

3.20

66.62

5.9

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

107

168

7.06

66.54

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

439

2029

3.19

65.48

6.2

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

12.89

64.81

1.9

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

181

472

4.51

64.36

21.1

12.8

14.18

15.98

12.65

172

457

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

135

277

5.52

63.89

4.6

2.7

212.45

192.64

1.31

128

265

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

122

228

6.00

63.83

2.0

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

17.49

63.81

2.8

1.5

44.15

30.69

3.11

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

247

814

3.76

63.46

4.7

2.4

0.21

0.22

g/l

0.50

235

765

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

170

427

4.64

63.35

1.9

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

149

337

5.07

63.06

11.0

3.3

24.09

25.22

mmol/l

2.75

139

326

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

637

3691

3.26

63.05

5.5

2.5

74.87

75.57

nmol/l

0.30

624

3368

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

186

6.50

62.50

2.6

1.5

—

(21494434) Karyotype in Bone marrow

10.18

62.01

1.6

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

112

198

6.29

61.98

5.7

3.1

31.36

33.66

umol/l

0.43

104

179

(3044640) Blood type and Crossmatch panel - Blood

515

2669

3.06

61.74

7.8

2.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

172

446

4.50

61.46

12.8

3.2

0.69

0.61

1.52

172

446

(3036489) Thrombin time

147

340

4.94

60.49

4.0

2.7

22.22

21.03

1.07

138

318

(3001122) Ferritin [Mass/volume] in Serum or Plasma

654

3913

3.21

59.89

8.8

3.0

322.80

124.77

ug/l

14.13

644

3675

(3017354) Segmented neutrophils/Leukocytes in Blood

9.45

59.47

10.6

3.5

55.09

53.70

0.17

(3025941) Bacteria identified in Stool by Culture

171

453

4.39

59.32

1.7

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

397

1830

3.03

57.94

2.5

1.5

2.08

2.42

g/l

2.89

319

1154

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

11.00

57.59

3.2

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

736

4796

3.47

56.63

24.9

5.4

6.83

6.65

mmol/l

1.38

717

4571

(3036481) Cortisol [Moles/volume] in Serum or Plasma

244

857

3.50

56.24

3.1

2.2

344.82

372.57

nmol/l

0.93

234

808

(3006922) Hepatitis E virus Ab [Presence] in Serum

9.78

55.41

1.2

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

9.42

54.62

5.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

9.42

54.62

5.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

9.42

54.62

5.0

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

103

190

5.97

54.41

4.7

2.2

120.00

132.29

g/l

4.80

147

(3008757) Leukocyte morphology finding [Identifier] in Blood

8.71

53.62

10.1

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

629

3817

2.96

53.50

8.0

2.7

—

estimate

—

(3031040) Bacteria [#/volume] in Urine by Automated count

763

5170

3.54

53.10

11.1

4.3

53.77

867.12

e6/l

0.95

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

9.99

52.97

1.7

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

13.10

52.45

2.6

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

169

485

4.03

52.29

2.8

1.7

—

(40768441) Liver Pathology biopsy report

9.95

51.16

3.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

12.82

50.79

2.6

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

15.87

50.54

4.2

2.0

0.28

0.33

e9/l

0.15

(3000012) Reticulocyte production index

100

7.71

49.75

4.8

2.4

0.95

0.97

0.10

(3021960) Folate [Moles/volume] in Serum or Plasma

431

2213

2.75

49.56

2.2

1.6

18.00

20.32

nmol/l

2.70

403

1888

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

14.84

48.75

6.5

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

14.84

48.75

6.5

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

522

2967

2.71

48.74

11.6

3.4

38.87

33.02

u/l

1.32

510

2816

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

9.12

48.70

4.9

2.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

8.44

48.68

1.1

1.0

—

(3028433) Virus identified in Specimen by Culture

14.38

47.90

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

14.38

47.90

6.5

1.7

—

(3021589) Normoblasts [#/volume] in Blood

613

3797

2.77

47.81

41.8

11.4

0.01

0.00

e9/l

0.59

517

3097

(3019832) Treponema pallidum Ab [Presence] in Serum

223

813

3.29

47.68

2.5

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

10.95

47.66

2.9

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

396

1998

2.70

46.46

14.5

4.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

777

5513

3.37

46.01

15.3

4.2

—

3.45

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

10.72

45.21

2.9

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

118

288

4.54

45.00

1.9

1.4

0.05

0.06

iu/ml

0.10

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

131

348

4.21

44.74

11.5

6.4

1.62

1.55

0.38

119

329

(3012501) Base excess in Blood by calculation

150

5.97

44.63

10.3

3.9

2.60

2.50

mmol/l

0.07

100

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

9.95

44.55

2.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

11.75

44.29

6.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

11.75

44.29

6.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

11.75

44.29

6.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

11.75

44.29

6.5

1.7

—

(3035933) Granulocytes/Leukocytes in Blood

201

5.21

43.99

7.5

3.2

52.51

57.19

1.92

201

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

7.32

43.72

4.3

2.3

33.17

32.69

0.37

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

215

805

3.17

43.63

6.1

2.4

39.85

99.76

u/l

0.51

199

693

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

8.22

43.39

1.4

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

154

471

3.71

43.07

13.0

8.3

23.43

24.69

mmol/l

3.16

144

451

(3007930) Methemoglobin/Hemoglobin.total in Blood

120

310

4.29

42.46

12.4

6.9

0.91

0.85

0.45

108

290

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

834

6291

3.91

42.27

39.9

8.4

90.50

79.39

u/l

4.41

827

5987

(3015736) pH of Urine

566

3509

2.54

41.75

8.4

3.3

6.26

6.18

0.95

318

2020

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

110

270

4.48

41.57

5.4

2.4

1.00

0.96

g/l

0.04

248

(3022313) Gas panel - Capillary blood

143

426

3.78

41.50

12.6

5.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

477

2740

2.51

41.41

11.6

3.5

2.31

2.36

mmol/l

6.26

458

2507

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

10.46

40.97

1.1

1.0

1538.54

1610.61

miu/ml

0.14

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

10.46

40.97

1.8

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

10.46

40.97

1.8

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

647

4333

2.59

39.48

11.5

3.6

0.00

estimate

0.50

198

877

(3009445) Proteinase 3 Ab [Units/volume] in Serum

129

370

3.88

39.46

2.7

1.3

17.35

14.07

iu/ml

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

8.64

39.27

3.5

2.9

1282.39

1192.90

0.10

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

444

2513

2.45

39.21

4.0

2.2

122.47

252.50

u/l

2.77

427

2397

(3009261) Glucose [Presence] in Urine by Test strip

653

4401

2.59

39.16

11.5

3.6

0.00

0.38

estimate

0.53

193

815

(3007566) Smooth muscle Ab [Titer] in Serum

108

274

4.32

39.05

1.4

1.2

83.85

81.67

titre

0.03

(21494890) Protein electrophoresis panel - 24 hour Urine

8.01

39.00

3.3

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

267

1191

2.74

38.87

2.0

1.7

1270.86

1169.51

nmol/l

0.91

226

904

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

367

1914

2.51

38.66

3.7

1.9

2.30

1.19

mg/l

1.63

328

1490

(3035350) Ketones [Presence] in Urine by Test strip

647

4366

2.55

38.28

11.6

3.6

13.91

1.98

estimate

0.63

200

883

(3047181) Lactate [Moles/volume] in Blood

223

4.63

37.89

15.0

8.7

1.23

1.30

mmol/l

0.45

197

(3039000) Anion gap in Blood by calculation

151

5.47

37.87

15.4

10.7

11.70

11.27

mmol/l

0.51

138

(3018572) Chloride [Moles/volume] in Blood

151

5.47

37.87

15.4

10.7

104.33

105.67

mmol/l

1.12

138

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

171

5.16

37.65

1.8

1.6

—

(3017732) Neutrophils [#/volume] in Blood

249

1088

2.75

37.60

6.2

3.5

4.18

5.24

e9/l

1.05

230

966

(3012516) Albumin [Mass/volume] in Urine

457

2664

2.39

37.22

9.8

3.5

127.22

47.70

mg/l

3.34

387

1712

(40768795) Lymph node Pathology biopsy report

7.33

36.78

1.7

1.1

—

(3023419) Bacteria identified in Sputum by Culture

126

5.83

36.61

2.8

3.2

—

(3051651) Icteric interference index of Serum or Plasma

8.74

35.85

7.1

3.7

0.85

0.84

index

0.02

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

110

304

3.97

35.34

3.9

2.3

271.55

403.16

ug/l

0.42

102

288

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

107

291

4.02

35.15

2.4

1.6

1.11

1.20

g/l

1.75

101

280

(3020682) Albumin/Creatinine [Ratio] in Urine

457

2714

2.33

35.03

11.2

4.1

25.74

8.75

mg/mmol

4.39

381

1683

(3037522) Nuclear Ab [Titer] in Serum

268

1261

2.57

34.50

1.7

1.4

609.37

470.96

titre

0.45

261

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

104

281

4.04

34.46

2.5

1.6

0.25

0.24

g/l

0.45

269

(3003181) Sodium [Moles/volume] in Urine

141

5.37

34.40

1.7

1.3

55.54

62.43

mmol/l

0.64

122

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

403

2284

2.34

34.28

5.8

3.2

3430.28

1009.55

ng/l

7.08

379

1919

(40758558) Short blood count panel - Blood

431

2518

2.32

34.08

23.1

6.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

10.38

33.78

2.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

10.38

33.78

2.9

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

479

2935

2.29

33.69

9.8

3.4

6.16

8.09

mmol/l

22.37

456

2502

(3034770) Mitochondria Ab [Titer] in Serum

102

277

4.01

33.54

1.4

1.2

583.33

888.00

titre

—

(3003694) ABO and Rh group [Type] in Blood

420

2449

2.29

33.11

1.9

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

6.86

32.19

1.3

1.1

215.00

104.00

titre

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

535

3479

2.25

31.97

2.5

2.0

97.00

96.12

pmol/l

0.18

344

1881

(3017704) Immunofixation for Urine

9.84

31.67

3.5

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

299

1537

2.39

31.31

7.2

3.9

624.10

495.51

ng/l

0.25

264

1163

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

6.42

30.80

1.5

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

9.76

28.98

3.2

2.1

64.72

64.42

ug/l

0.01

(3044290) Cell count panel - Cerebral spinal fluid

168

4.56

28.82

2.4

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

8.87

28.55

1.7

1.6

3885.71

4533.33

titre

—

(3048689) Calprotectin [Mass/mass] in Stool

238

1161

2.41

27.58

4.2

2.5

219.17

125.36

ug/g

4.02

212

936

(3003434) Protein [Mass/volume] in Pleural fluid

5.95

27.50

1.6

1.5

680.75

32.17

g/l

0.49

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

142

538

2.93

27.40

7.1

3.6

258.62

176.79

ng/l

1.39

132

489

(3052851) Hemolysis interference index of Serum or Plasma

224

3.92

26.64

6.3

3.5

5.00

2.07

index

2.23

136

(3023199) Leukocytes [#/volume] in Pleural fluid

6.34

26.48

1.4

981.86

2442.02

e6/l

1.11

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

249

3.75

26.44

1.5

2.4

12.73

11.79

mg/l

0.38

234

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

190

4.14

26.16

2.0

1.2

3.97

3.69

mmol/l

0.89

177

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

10.29

25.71

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

770

6083

2.48

25.58

10.8

4.3

20.34

10.97

mm/h

31.26

753

5708

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

29.33

25.52

4.2

3.7

33.52

19.48

mg/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

114

5.06

25.33

4.0

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

294

3.44

24.98

1.2

1.3

264.04

235.35

miu/ml

0.20

146

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

5.50

24.89

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

105

353

3.22

24.84

13.9

5.7

24.06

24.85

mmol/l

2.04

105

339

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

116

4.97

24.83

4.0

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

116

4.97

24.83

4.0

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

190

4.02

24.51

2.4

1.5

188.20

529.86

e6/l

0.38

143

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

187

4.03

24.23

2.3

1.5

79.05

12.21

e6/l

0.42

136

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

23.46

24.03

2.7

1.4

—

(3037121) Protein [Mass/volume] in Urine

286

3.42

23.98

8.6

4.1

1005.46

273.26

mg/l

1.14

141

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

137

4.53

23.73

1.8

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

137

4.53

23.73

1.8

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

325

3.25

23.69

1.5

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

243

3.60

23.64

5.1

2.3

0.00

g/l

-0.00

218

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

4.95

23.39

4.2

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

110

4.95

23.39

4.1

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

111

4.90

23.14

4.2

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

7.02

22.19

6.2

8.2

30.50

71.35

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

17.60

21.91

3.2

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

456

3069

1.94

21.73

5.6

3.6

62.68

54.52

ng/l

0.12

380

2110

(3029937) Albumin [Presence] in Urine by Test strip

372

2355

1.96

21.08

11.6

3.7

0.00

0.01

estimate

1.34

179

827

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

137

4.28

21.07

1.5

1.2

4.55

3.61

u/ml

0.22

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

38.15

20.85

2.6

5.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

102

373

2.95

20.80

2.4

1.9

10.41

7.39

iu/ml

0.26

(3026389) Candida sp identified in Specimen by Organism specific culture

5.08

20.56

1.4

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

6.87

20.51

4.6

1.6

201.06

92.65

ng/l

1.72

(3042631) Mycobacterium sp identified in Specimen

115

4.54

20.34

2.4

3.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

8.33

19.71

3.2

2.1

553.95

717.88

e6/l

0.13

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

4.77

19.56

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

285

3.14

19.49

6.7

1.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

155

3.92

19.38

1.5

1.2

91.54

28.14

u/l

1.24

132

(3014765) Yersinia sp identified in Stool by Organism specific culture

239

3.32

19.29

1.6

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

268

3.17

18.96

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.51

18.92

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

242

3.28

18.91

1.6

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

6.70

18.83

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

243

3.27

18.78

1.6

1.1

—

(3047189) Immunofixation for 24 hour Urine

7.84

18.76

2.7

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

137

4.04

18.54

1.5

1.2

1.93

2.98

u/ml

0.57

(3045788) Cell count panel - Pleural fluid

5.64

18.48

1.5

1.4

—

(3045414) Leukocytes [Presence] in Urine

160

772

2.29

18.38

5.5

2.0

0.02

0.03

estimate

0.17

172

(3012441) Differential panel - Pleural fluid

5.47

18.37

1.6

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

7.61

18.31

1.0

1.2

—

(40757373) Influenza virus identified in Isolate

16.93

17.94

2.4

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

318

2.91

17.71

1.6

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.68

17.55

8.5

2.9

1.45

1.42

0.02

(3024980) IgG subclass 4 [Mass/volume] in Serum

157

3.73

17.49

1.3

1.6

0.47

0.77

g/l

1.41

127

(3000570) Elastase.pancreatic [Mass/mass] in Stool

265

3.08

17.43

1.5

278.76

286.63

ug/g

0.12

152

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

6.17

17.40

4.1

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

139

646

2.35

17.37

2.6

2.4

15.18

7.41

ug/l

1.23

125

583

(3016018) Differential panel - Cerebral spinal fluid

4.65

16.95

1.9

1.6

—

(3045424) Erythrocytes [Presence] in Urine

103

424

2.61

16.69

5.8

2.1

0.00

1.76

estimate

0.51

144

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

461

3296

1.78

16.58

10.8

3.4

0.58

0.02

estimate

0.47

173

734

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

18.31

16.53

1.4

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

263

3.01

16.43

3.7

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

30.64

16.15

2.1

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.23

16.09

1.4

12490.18

39577.09

e6/l

1.50

(4195642) Thrombophilia screening test

120

3.98

15.90

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

448

3208

1.76

15.77

2.9

2.1

—

(40765096) Chromosome analysis panel by Banding

7.34

15.73

1.2

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

674

5437

1.85

15.67

4.6

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

239

2.99

14.83

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

257

1589

1.85

14.63

1.9

1.7

517.21

22356017.47

pmol/l

1.19

235

1333

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

14.45

14.59

1.4

18.12

4.83

pmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

193

3.19

14.54

18.3

1.5

1.09

0.82

nmol/l

1.93

164

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

709

5880

1.84

14.20

10.1

3.4

68.43

48.97

u/l

4.33

692

5589

(40768797) Stomach Pathology biopsy report

199

1143

1.94

14.17

1.4

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.77

14.08

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

347

2.59

13.98

1.3

1.2

1.34

1.40

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.70

13.84

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

351

2417

1.72

13.66

10.4

3.0

1.45

0.05

estimate

0.48

172

698

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.54

13.59

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

130

3.59

13.47

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

18.54

13.40

2.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

128

640

2.16

13.28

13.7

3.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

12.38

13.14

16.4

7.9

7.83

5.27

kpa

2.35

(3002256) Pathology report gross observation

184

1063

1.91

12.76

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

4.59

12.67

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

4.16

12.65

3.0

4.1

—

(40758292) HTLV I+II Ab panel - Serum

11.20

12.57

1.7

1.4

—

(3048879) Bone marrow aspiration report

11.83

12.35

4.6

2.4

—

(3044889) 12 lead EKG panel

687

5739

1.73

12.29

7.0

3.9

—

8418.08

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

197

2.96

12.21

5.3

2.4

301.73

90.30

ug/min

0.94

113

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

145

785

2.00

12.12

3.6

4.6

22.02

26.19

ug/l

0.10

122

646

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

18.32

12.08

18.8

17.1

0.29

0.33

umol/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

4.39

12.01

1.2

1.1

98.03

109.81

pmol/l

0.57

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

323

2.51

11.97

3.1

3.6

111.80

4186.73

u/ml

0.74

279

(3022145) Colonoscopy Study observation

173

999

1.90

11.96

1.9

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

154

3.16

11.57

1.4

1.3

573.33

358.33

titre

—

(4268621) Lupus anticoagulant assay

100

3.70

11.43

2.5

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

15.26

11.33

2.1

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

3.80

11.20

1.4

1.3

6.19

6.84

g/l

0.26

(3028192) IgG subclass 2 [Mass/volume] in Serum

3.80

11.20

1.4

1.3

1.87

2.88

g/l

2.58

(3024139) IgG subclass 3 [Mass/volume] in Serum

3.80

11.20

1.4

1.3

0.46

0.36

g/l

0.62

(4062490) Immunoglobulin typing, IgG

3.76

11.04

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

14.09

10.99

1.8

1.1

57.50

54.46

ng/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

8.98

10.80

3.5

1.8

4161.13

4116.47

e6/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

4.79

10.28

1.4

1.1

—

(3008295) Osmolality of Serum or Plasma

3.56

10.24

1.1

1.5

275.48

280.83

mosm/kgh2o

0.65

(3040151) Glucose [Moles/volume] in Capillary blood

3.69

10.16

3.3

5.2

6.76

7.26

mmol/l

0.43

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

4.28

10.14

1.2

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

113

596

2.02

10.11

2.4

8.80

17.33

au/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

14.77

10.02

4.8

3.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

9.67

9.79

1.6

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

421

2.18

9.76

1.6

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

7.48

9.73

3.2

3.8

171.30

36.50

au/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.49

9.59

2.4

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

3.33

9.52

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

17.74

9.42

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

163

2.85

9.35

1.1

12.22

15.42

au/ml

—

(3044007) Cell count panel - Peritoneal fluid

8.41

9.09

3.3

1.7

—

(3044927) Protein electrophoresis panel - Urine

3.72

9.05

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

166

2.80

9.04

3.0

4.2

692.65

1847.96

u/ml

0.34

157

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

6.90

8.87

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.95

8.86

1.8

1.2

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

10.83

8.81

4.7

2.1

1.63

3.33

0.68

(3005322) IgE [Units/volume] in Serum or Plasma

115

641

1.90

8.75

1.7

1.3

384.34

245.84

u/ml

0.32

600

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

876

8110

2.19

8.60

79.6

15.1

21.35

23.78

mg/l

2.28

839

6576

(3049717) Cytology report of Urine Cyto stain

294

2.30

8.58

2.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

10.15

8.54

1.6

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

10.15

8.54

1.7

1.1

—

(3014891) Appearance of Pleural fluid

20.23

8.48

1.6

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.63

8.45

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

9.02

8.06

1.0

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

3.29

7.85

3.6

2.6

26.34

7.98

umol/l

0.94

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

267

2.29

7.80

1.3

1.2

1.04

2.56

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

18.53

7.61

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

499

1.94

7.58

3.0

3.7

4.22

4.64

pmol/l

2.98

444

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

8.95

7.56

1.1

1.0

—

(3004451) EKG impression Narrative

3.86

7.56

1.6

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

255

2.27

7.31

1.3

1.2

1.83

2.59

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

264

1928

1.51

7.12

9.2

3.7

1.02

1.80

kg/l

0.50

208

1292

(3017569) Oxygen content in Arterial blood

4.11

7.10

1.6

3.5

14.71

17.40

2.59

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

12.14

7.09

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.12

7.04

1.8

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.06

7.01

1.3

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.06

7.01

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.06

7.01

1.3

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

234

2.29

6.98

1.7

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.52

6.94

1.4

1.1

—

(40768443) Skin Pathology biopsy report

357

2.04

6.88

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

352

2.04

6.78

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.31

6.77

1.4

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

227

1621

1.53

6.76

1.8

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.49

6.65

1.7

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

255

2.19

6.48

1.4

1.2

9.88

9.62

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

11.11

6.30

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

18.15

6.27

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

213

1524

1.51

6.23

4.6

3.0

2.46

2.44

mmol/l

0.70

196

1385

(3003740) Influenza virus B Ag [Presence] in Specimen

189

2.34

6.12

1.4

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

190

2.32

6.05

1.4

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

117

2.71

6.04

1.5

1.4

24.23

25.75

ng/l

0.14

117

(3021788) Differential panel - Synovial fluid

159

2.45

6.02

1.9

1.6

—

(21494755) Public health laboratory ask at order entry panel

912

0.47

6.02

1.2

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.31

5.93

2.2

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.31

5.93

2.2

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.31

5.93

2.2

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

11.21

5.80

5.3

2.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

11.21

5.80

5.1

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

138

2.52

5.75

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

7.58

5.64

3.3

2.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

6.57

5.57

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

269

2056

1.43

5.55

1.4

1.3

1.55

1.68

u/ml

0.08

585

(3034426) Prothrombin time (PT)

5.90

5.54

1.3

1.5

29.00

29.58

0.09

(1761868) Lipid panel - Serum or Plasma

280

3531

0.71

5.54

4.1

3.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

3.27

5.47

1.2

1.1

42.13

38.75

mg/l

0.09

(3009214) Lutropin [Units/volume] in Serum or Plasma

309

1.97

5.43

1.9

1.6

10.19

8.99

u/l

0.33

253

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

16.13

5.41

3.0

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.26

5.39

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.67

5.38

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

5.67

5.38

3.0

2.2

39.80

41.48

g/l

0.37

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.06

5.27

2.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

5.45

5.23

1.1

—

(3030703) Everolimus [Mass/volume] in Blood

+∞

5.21

17.0

0.0

4.24

—

ug/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

8.41

5.07

1.8

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

430

3599

1.36

5.04

2.9

1.9

1.54

1.39

mmol/l

3.28

405

3066

(3006571) Granulocytes/Leukocytes in Synovial fluid

2.73

5.04

2.2

1.7

53.33

58.03

0.21

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

270

1.98

4.92

1.8

2.4

5208.38

5030.75

u/l

0.01

107

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

701

6353

1.41

4.88

5.0

4.2

14.70

14.67

pmol/l

0.11

675

5874

(3019550) Sodium [Moles/volume] in Serum or Plasma

869

8232

1.75

4.87

86.5

17.4

138.86

139.73

mmol/l

21.15

864

8079

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1048

0.55

4.86

2.0

3.51

3.63

ratio

0.29

847

(3023103) Potassium [Moles/volume] in Serum or Plasma

870

8246

1.75

4.84

89.9

17.6

4.06

3.97

mmol/l

13.80

865

8076

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

157

2.28

4.81

1.1

29.74

94.89

iu/ml

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

11.51

4.79

1.3

—

(3026480) Teichoate Ab [Titer] in Serum

14.09

4.58

1.0

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

10.07

4.52

1.1

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.27

4.46

4.8

3.0

7.17

4.30

ug/l

0.75

(3013005) Retinol [Moles/volume] in Serum or Plasma

3.37

4.34

2.3

2.0

1.77

1.97

umol/l

0.51

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

11.74

4.28

1.7

2.8

3.61

3.35

mg/l

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

776

0.52

4.27

1.7

1.8

3.73

3.52

mmol/l

0.50

570

(3004616) Nuclear Ab [Presence] in Serum

2.54

4.24

1.5

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

375

1.76

4.20

2.8

1.2

0.93

0.90

g/l

0.63

375

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.85

4.19

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.83

4.14

1.2

1.4

—

(3000330) Specific gravity of Urine by Test strip

355

1.77

4.10

10.7

3.0

1.02

ratio

3.02

330

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

10.06

4.01

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

10.06

4.01

1.6

1.4

—

(3023410) Appearance of Cerebral spinal fluid

101

2.41

3.84

3.4

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

120

2.29

3.83

3.1

3.2

1.10

0.88

nmol/l

0.64

100

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.09

3.82

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.80

3.77

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.94

3.75

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.50

3.65

2.0

2.2

25.90

21.17

nmol/l

0.64

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.44

3.63

1.2

1.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

185

1.98

3.57

1.6

1.8

—

(3041354) Potassium [Moles/volume] in Venous blood

2.53

3.56

2.9

2.5

4.26

4.02

mmol/l

1.10

(3035285) Chloride [Moles/volume] in Venous blood

2.53

3.56

2.9

2.5

108.20

105.41

mmol/l

2.18

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.11

3.40

1.3

83.60

88.47

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.04

3.36

2.0

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

5.75

3.34

4.6

9.0

9.81

10.61

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.75

3.34

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

4.38

3.31

3.2

1.8

40.63

—

au/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.96

3.29

1.2

2.0

98.80

91.19

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

124

902

1.43

3.27

3.3

2.4

13.44

13.50

nmol/l

0.03

117

824

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.38

3.17

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

223

1.83

3.15

1.9

1.6

7974.46

12207.61

e6/l

0.65

163

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.43

3.15

2.9

2.5

1.20

1.19

mmol/l

0.69

(4024509) Urine culture

346

1.66

3.10

5.0

1.8

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.83

3.09

1.4

1.2

0.55

0.52

ratio

—

(3025130) Human papilloma virus identified in Specimen

119

2.13

3.06

2.7

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.37

3.00

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

4.74

2.92

4.1

1.3

4.64

9.33

mmol/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.40

2.90

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.47

2.90

4.2

2.4

6.29

9.75

mg/l

1.58

(3044242) Glucose [Moles/volume] in Arterial blood

2.72

2.89

1.2

3.2

10.38

8.22

mmol/l

0.43

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

238

1.76

2.86

1.2

1.1

12.11

8.33

eliau/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

451

1.55

2.84

2.4

1.6

0.24

0.31

mg/l

0.47

225

(3001019) Free T4 and TSH panel - Serum or Plasma

462

0.51

2.83

2.1

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

209

1.80

2.82

1.3

1.2

21.04

42.69

u/ml

—

(3022621) pH of Urine by Test strip

635

1.46

2.80

5.4

2.1

6.00

6.09

0.48

410

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.47

2.80

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.10

2.77

2.8

5.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

8.37

2.75

1.0

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.37

2.75

9.4

5.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.30

2.69

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.30

2.69

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.69

2.60

1.9

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.15

2.56

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

164

1.86

2.56

7.3

4.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.75

2.55

1.1

221.25

220.07

iu/ml

0.00

(3033099) Centromere Ab [Titer] in Serum

5.48

2.54

1.2

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.62

2.54

2.4

1.9

27.00

28.77

umol/l

0.20

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.52

2.54

1.2

1.4

—

20.90

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

136

1.94

2.52

2.3

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

2.29

2.52

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

217

1.73

2.52

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

2.40

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.23

2.38

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

199

1633

1.28

2.38

1.5

1.3

20.72

30.71

iu/ml

1.58

488

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.84

2.34

1.2

1.0

—

(36660697) Celiac disease serology panel - Serum

690

1.39

2.23

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.58

2.21

1.6

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.70

2.21

1.3

2.1

62.50

79.08

umol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

149

1192

1.30

2.17

2.5

1.9

1.45

1.46

0.10

132

1057

(3006653) Thiamine [Moles/volume] in Blood

2.64

2.14

1.6

1.3

134.00

143.80

nmol/l

0.25

(44806071) Cardiolipin IgM antibody measurement

5.02

2.07

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

3.35

1.96

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.77

1.93

1.2

1.4

69.67

71.75

ug/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

450

1.43

1.90

1.2

1.1

—

88.10

titre

—

(3023511) Choriogonadotropin [Units/volume] in Urine

143

1.77

1.90

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

144

1171

1.27

1.86

1.8

1.5

—

(1002224) Polysomnography panel

488

0.62

1.85

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

4.18

1.82

2.0

1.7

1.16

1.26

umol/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

123

1.81

1.4

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

118

939

1.29

1.81

1.5

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.02

1.80

1.6

1.3

5.17

3.97

u/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.36

1.78

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

128

1032

1.28

1.77

1.6

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

782

7516

1.24

1.71

6.1

5.1

1.94

1.88

mu/l

0.77

758

6994

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

802

7735

1.25

1.66

7.3

4.2

1.52

1.32

mmol/l

8.50

775

7204

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.59

1.66

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.59

1.66

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.59

1.66

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.59

1.66

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

797

7687

1.24

1.62

11.8

6.1

39.61

39.00

mmol/mol

1.07

773

7260

(3024869) Neuronal Ab [Presence] in Serum

3.58

1.61

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.21

1.57

2.2

1.3

9.93

6.75

ug/l

0.36

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

662

1.31

1.55

1.9

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.74

1.43

3.5

3.7

4.75

4.98

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.74

1.43

3.5

3.7

11.44

10.45

kpa

—

(3039443) Prostate specific Ag panel - Serum or Plasma

200

0.49

1.43

1.9

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.32

1.43

1.1

1.4

146.11

192.94

mmol/24h

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.26

1.40

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

148

1739

0.82

1.38

3.0

3.1

0.85

0.71

ug/l

1.05

114

1049

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

809

7844

1.23

1.37

61.4

14.2

67.31

84.46

ml/min/173m2

45.58

780

7228

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

368

1.38

1.34

1.7

1.9

35.62

39.39

nmol/l

0.48

354

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.95

1.28

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

2.30

1.27

2.5

1.3

0.00

0.09

estimate

—

(40761511) CBC panel - Blood by Automated count

859

8399

1.27

1.23

58.8

13.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.68

1.10

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

2.39

1.09

2.4

3.9

290.60

3821.57

u/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

881

8656

1.29

1.08

88.4

19.1

118.09

76.40

umol/l

33.87

876

8574

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

172

1509

1.17

1.08

1.4

1.3

6.04

10.79

u/ml

1.05

598

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.20

1.08

1.6

1.2

10.71

8.32

ug/l

—

(3014271) Vancomycin [Susceptibility]

2.20

1.08

2.0

2.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.28

1.03

1.0

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

155

1.50

1.02

3.7

29.23

28.62

mg/l

0.03

102

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.90

1.01

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.90

0.94

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

447

1.27

0.92

2.1

1.5

27.71

25.96

iu/l

0.11

377

(3000492) Spirometry study

109

936

1.19

0.90

2.6

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

449

1.26

0.89

2.2

2.1

—

(3027944) Amphetamines [Presence] in Urine

425

0.74

0.88

1.8

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

229

1.37

0.87

1.9

2.0

3.62

4.24

iu/l

0.13

(4034850) Laboratory test

249

0.68

0.83

13.8

10.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.88

0.82

3.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

446

1.25

0.81

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.77

0.76

4.0

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

533

1.22

0.75

2.6

2.2

—

(3028300) Cannabinoids [Presence] in Urine

425

0.77

0.75

2.5

2.0

—

(3024263) Appearance of Synovial fluid

1.85

0.73

1.9

1.7

—

(3027008) Opiates [Presence] in Urine

423

0.77

0.73

2.5

2.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.01

0.72

4.8

6.8

14.20

8.00

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.01

0.72

2.4

3.4

31.60

44.24

—

(3000764) Benzodiazepines [Presence] in Urine

422

0.77

0.72

2.5

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

241

0.70

0.72

1.3

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

363

0.76

0.69

1.2

1.1

1.45

1.52

g/l

0.63

363

(3016879) Cocaine [Presence] in Urine

395

0.78

0.67

2.5

2.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.63

0.67

1.9

3.0

3016.87

210.22

ug/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

290

1.25

0.60

1.6

1.9

193.86

217.61

pmol/l

0.89

275

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

302

2849

1.09

0.58

4.3

5.1

2.00

2.09

ug/l

0.21

288

2589

(3008898) HLA-B27 [Presence]

374

1.21

0.57

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

872

8618

1.17

0.57

50.2

11.9

29.54

27.54

u/l

1.77

865

8412

(40768800) Prostate Pathology biopsy report

183

0.71

0.55

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.43

0.52

1.3

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

257

0.77

0.49

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

201

0.74

0.49

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

308

1.21

0.48

1.8

1.7

—

(4211845) Urine protein measurement

1.62

0.43

2.6

2.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

113

1.33

0.43

1.4

—

0.63

nmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

184

0.76

0.42

4.1

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

294

0.81

0.42

1.3

1.6

1319.82

910.47

mu/l

0.79

246

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

3.02

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.41

0.0

1.8

—

8.14

—

(3000963) Hemoglobin [Mass/volume] in Blood

885

8914

0.88

0.39

102.9

23.1

122.28

137.30

g/l

101.03

880

8841

(3026361) Erythrocytes [#/volume] in Blood

885

8911

0.88

0.36

102.3

22.9

4.08

4.56

e12/l

81.66

875

8737

(3010813) Leukocytes [#/volume] in Blood

885

8911

0.88

0.36

102.4

23.0

7.14

6.69

e9/l

2.34

877

8732

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

885

8911

0.88

0.36

106.4

23.5

37.10

40.89

82.28

880

8831

(4281824) Cell count and differential, peritoneal fluid

1.36

0.36

1.6

1.2

—

(3007461) Platelets [#/volume] in Blood

885

8906

0.89

0.32

102.6

23.0

228.35

251.17

e9/l

16.09

876

8753

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.71

0.31

1.3

1.6

66.39

51.73

ug/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

112

1.25

0.28

1.8

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.28

0.28

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.27

0.27

1.5

1.4

128.00

182.71

pmol/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

140

1.22

0.27

1.1

16.47

2.54

eliau/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

890

1.08

0.25

17.2

6.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

772

7795

0.95

0.25

8.4

5.0

6.03

5.92

mmol/l

1.11

742

7236

(1001926) Buprenorphine [Presence] in Urine by Screen method

338

0.88

0.23

2.6

1.9

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.32

0.23

1.4

1.3

28.24

26.56

nmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

112

1061

1.06

0.22

2.1

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

146

0.82

0.22

1.3

1.6

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

2.4

—

0.60

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

105

0.76

0.21

1.3

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

6.0

—

8.08

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.25

0.20

1.5

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

142

0.84

0.17

1.3

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

818

8129

1.05

0.17

8.1

5.1

4.43

4.66

mmol/l

9.73

798

7650

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.11

0.17

1.1

1.4

106.43

79.52

umol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.72

0.17

1.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.71

0.16

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

183

0.87

0.16

1.2

1.1

0.20

2.16

u/ml

—

(40768793) Breast Pathology biopsy report

193

0.88

0.16

1.6

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.75

0.15

1.2

—

(44806420) Estimation of glomerular filtration rate

102

1.18

0.15

2.3

2.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

296

0.91

0.15

4.6

2.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

171

0.88

0.14

1.3

1.5

1.75

1.10

ratio

—

107

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

171

0.88

0.14

1.3

1.5

1.64

1.19

ratio

—

107

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

171

0.88

0.14

1.3

1.5

0.99

0.95

ratio

—

107

(3038177) Helicobacter pylori Ab [Presence] in Serum

141

1.14

0.14

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

598

1.06

0.13

1.2

1.3

159.26

138.73

u/ml

0.14

254

(3014133) Dog dander IgE Ab [Units/volume] in Serum

159

0.88

0.13

1.1

1.17

3.23

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

169

0.89

0.12

1.2

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

263

1.07

0.08

2.1

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

214

0.93

0.07

1.3

1.1

2.96

2.16

u/ml

0.14

117

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

813

8105

1.02

0.07

8.0

5.0

1.35

1.44

mmol/l

7.86

792

7588

(3013139) Helicobacter pylori Ag [Presence] in Stool

599

0.97

0.06

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

100

981

1.02

0.05

5.7

4.7

31.35

31.57

0.07

646

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

130

0.92

0.04

1.4

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.09

0.03

1.6

1.3

—

nmol/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

823

8219

1.01

0.02

8.2

5.7

2.52

2.75

mmol/l

12.98

800

7704

(3003888) Timothy IgE Ab [Units/volume] in Serum

184

0.98

0.00

1.2

1.0

6.17

6.64

u/ml

—

104

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

227

2275

1.00

0.00

4.1

4.2

25.15

20.85

2.93

112

1005

(3023430) Cat dander IgE Ab [Units/volume] in Serum

147

1.02

0.00

1.2

1.1

1.42

6.50

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

179

1.01

0.00

1.2

1.0

0.54

1.43

u/ml

0.62

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

975

0.99

0.00

2.1

—

(44813793) Dust mix specific IgE antibody measurement

0.95

0.00

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

365.13

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

10.57

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

516.60

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

56.35

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.80

—

(3020491) Glucose [Moles/volume] in Blood

0.91

-0.00

6.0

1.8

9.60

6.41

mmol/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

0.00

-0.00

0.0

1.3

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

67.57

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

453.44

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_CMV_WIDE – Cytomegaloviral disease, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cytomegaloviral disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Cytomegaloviral disease, including avohilmo (AB1_CMV_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints